Skip to main content

HLS · HLS Therapeutics Inc. · Investor Relations

4.4100 CAD -0.0300 (-0.68%) At close · Nov 6 Intraday price with Plus
Market Cap
136.42M CAD
Shares
30.94M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

No Investor Relations Content

No press releases or events have been collected for this stock yet.